Vitamin B12 deficiency in adolescents and young adults with phenylketonuria.

PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders. J Inherit Metab Dis (2009) 1.08

The truth of treating patients with phenylketonuria after childhood: the need for a new guideline. J Inherit Metab Dis (2008) 1.03

Nutritional Consequences of Adhering to a Low Phenylalanine Diet for Late-Treated Adults with PKU : Low Phe Diet for Adults with PKU. JIMD Rep (2012) 0.89

Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU). J Inherit Metab Dis (2006) 0.89

Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice. J Inherit Metab Dis (2002) 0.81

Mild hyperphenylalaninemia: to treat or not to treat. J Inherit Metab Dis (2011) 0.78

Phenylketonuria: treatment in adolescence and adult life. Eur J Pediatr (1996) 0.77

Nutritional status of patients with phenylketonuria in Japan. Mol Genet Metab Rep (2016) 0.75

Micronutrient in hyperphenylalaninemia. Data Brief (2015) 0.75

Late effects of phenylketonuria. Arch Dis Child (1995) 0.75

The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis (2017) 0.75

Synergism of carbenicillin and gentamicin against enterococci. Antimicrob Agents Chemother (1973) 2.60

Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet (1992) 2.41

Phenylketonuria: mental development, behavior, and termination of low phenylalanine diet. J Pediatr (1968) 2.33

Comparative pharmacokinetics of amikacin and kanamycin. Clin Pharmacol Ther (1974) 2.15

The genetic mucopolysaccharidoses. Medicine (Baltimore) (1965) 2.04

Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus. J Infect Dis (1975) 1.94

Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis (2009) 1.89

Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. N Engl J Med (1990) 1.78

Pancreatitis in patients with organic acidemias. J Pediatr (1994) 1.73

Postanesthetic apnea in full-term infants after pyloromyotomy. Anesthesiology (1994) 1.67

Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate. Mol Genet Metab (2011) 1.60

Copper-histidine therapy for Menkes disease. J Pediatr (1993) 1.56

Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease. Am J Hum Genet (1991) 1.44

A simple method for the maintenance of oxygen saturation following intravenous induction of anaesthesia with propofol. Anaesthesia (1994) 1.39

The diagnostic interview for borderline patients. Am J Psychiatry (1981) 1.39

The conversion of phenylalanine to tyrosine in man. Direct measurement by continuous intravenous tracer infusions of L-[ring-2H5]phenylalanine and L-[1-13C] tyrosine in the postabsorptive state. Metabolism (1982) 1.38

Enzyme replacement therapy by renal allotransplantation in Fabry's disease. N Engl J Med (1972) 1.38

Ticarcillin vs carbenicillin: clinical pharmacokinetics. Clin Pharmacol Ther (1975) 1.37

Electrophoretic and functional heterogeneity of pepsinogen in several species. Nature (1966) 1.34

Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. Neurology (2007) 1.34

Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. Am J Med Genet (1998) 1.31

Barth syndrome: clinical observations and genetic linkage studies. Am J Med Genet (1994) 1.31

Solar wind dynamic pressure and electric field as the main factors controlling Saturn's aurorae. Nature (2005) 1.30

Arteriopathy and coarctation of the abdominal aorta in children with mucopolysaccharidosis: imaging findings. AJR Am J Roentgenol (1991) 1.29

Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin. Infection (1974) 1.28

Clinical pharmacology of amikacin and kanamycin. J Infect Dis (1976) 1.26

Mutation characterization and genotype-phenotype correlation in Barth syndrome. Am J Hum Genet (1997) 1.24

A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am J Hum Genet (2001) 1.22

Pharmacokinetics of metronidazole as determined by bioassay. Antimicrob Agents Chemother (1974) 1.21

Malnutrition with early treatment of phenylketonuria. Pediatr Res (1970) 1.16

An Earth-like correspondence between Saturn's auroral features and radio emission. Nature (2005) 1.10

Pregnancy outcome and infant development following gestational cocaine use by social cocaine users in Toronto, Canada. Clin Invest Med (1992) 1.09

Congenital heart disease in maternal phenylketonuria: report from the Maternal PKU Collaborative Study. Pediatr Res (2001) 1.09

Ras transformation of cloned rat embryo fibroblasts results in increased rates of protein synthesis and phosphorylation of eukaryotic initiation factor 4E. J Biol Chem (1992) 1.08

High-level gentamicin resistance in Enterococcus faecalis bacteremia. J Infect Dis (1991) 1.07

Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy. J Child Neurol (1995) 1.07

Funding crisis of the national health research and development program. Can Med Assoc J (1979) 1.07

Early copper-histidine treatment for Menkes disease. Nat Genet (1996) 1.05

Ceramide trihexosidosis (fabry's disease) without skin lesions. N Engl J Med (1971) 1.05

Human sulfite oxidase R160Q: identification of the mutation in a sulfite oxidase-deficient patient and expression and characterization of the mutant enzyme. Proc Natl Acad Sci U S A (1998) 1.05

Evaluation of migration models that might be used in support of regulations for food-contact plastics. Food Addit Contam (2005) 1.03

Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis. Biochem J (2000) 1.02

Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics (1996) 1.01

Maternal phenylketonuria (PKU)--a review. Clin Biochem (1987) 1.00

Ornithine transcarbamylase deficiency presenting with strokelike episodes. J Pediatr (1993) 0.99

Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews. Am J Med Genet (1999) 0.99

NADH-coenzyme Q reductase (complex I) deficiency: heterogeneity in phenotype and biochemical findings. J Inherit Metab Dis (1996) 0.98

Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus. Am J Med Genet (1991) 0.98

A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies. Hum Mutat (1992) 0.98

Familial dissecting aortic aneurysm. A report of three cases within two generations. Br Heart J (1967) 0.97

Amerindian pyruvate carboxylase deficiency is associated with two distinct missense mutations. Am J Hum Genet (1998) 0.96

Electroretinography and fundus oculi findings in Hurler's disease and allied mucopolysaccharidoses. Arch Ophthalmol (1965) 0.96

Detection of phenylketonuric heterozygotes. Clin Chem (1971) 0.95

Calcium ion activity in the sick neonate: effect of bicarbonate administration and exchange transfusion. Pediatr Res (1972) 0.95

Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the Maternal Phenylketonuria Collaborative Study. Pediatrics (1999) 0.94

Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause for recurrent myoglobinuria and encephalopathy. Ann Neurol (1991) 0.94

The international study of pregnancy outcome in women with maternal phenylketonuria: report of a 12-year study. Am J Obstet Gynecol (2000) 0.93

Joubert syndrome with congenital hepatic fibrosis: an entity in the spectrum of oculo-encephalo-hepato-renal disorders. Am J Med Genet (1994) 0.93

Nutrition and reproductive outcome in maternal phenylketonuria. Eur J Pediatr (1996) 0.92

Osteochondritis dissecans with associated malformations in two brothers. A review of familial aspects. J Bone Joint Surg Am (1967) 0.92

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. Mol Genet Metab (2013) 0.92

Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry (1995) 0.91

Catabolism of exogenous and endogenous sphingomyelin and phosphatidylcholine by homogenates and subcellular fractions of cultured neuroblastoma cells. Effects of anesthetics. J Neurochem (1985) 0.91

Ethylmalonic and methylsuccinic aciduria in ethylmalonic encephalopathy arise from abnormal isoleucine metabolism. Metabolism (1998) 0.91

Phenylalanine hydroxylase gene mutations in the United States: report from the Maternal PKU Collaborative Study. Am J Hum Genet (1996) 0.91

Pulmonary infiltration in Niemann-Pick disease type C. J Inherit Metab Dis (1996) 0.90

Evolution of the neuroimaging changes in fucosidosis type II. J Inherit Metab Dis (1996) 0.89

Vitamin B12 deficiency in adolescents and young adults with phenylketonuria. Eur J Pediatr (1996) 0.89

The effect of vincristine on skeletal muscle in the rat. A correlative histochemical, ultrastructural and chemical study. J Neuropathol Exp Neurol (1972) 0.89

A novel mitochondrial DNA mutation in COX1 leads to strokes, seizures, and lactic acidosis. Neuropediatrics (2009) 0.89

Glaucoma as an early complication of Hurler's disease. Arch Dis Child (1988) 0.89

Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model? Biochem Med Metab Biol (1994) 0.88

Craniosynostosis associated with partial duplication of 15q and deletion of 2q. Am J Med Genet (1992) 0.88

Genotype-phenotype correlation in vanishing white matter disease. Neurology (2010) 0.88

Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia. J Med Genet (1978) 0.87

Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease. Am J Hum Genet (1996) 0.87

Feto-maternal plasma phenylalanine concentration gradient from 19 weeks gestation to term. Clin Chim Acta (1994) 0.87

Pathways of sphingomyelin metabolism in cultured fibroblasts from normal and sphingomyelin lipidosis subjects. J Biol Chem (1983) 0.87

Neutral glycosphingolipids of serum lipoproteins in Fabry's disease. Biochim Biophys Acta (1976) 0.86

Enzyme replacement therapy for Gaucher's disease: the early Canadian experience. CMAJ (1998) 0.86

"Hypotyrosinemia" in phenylketonuria. Mol Genet Metab (2000) 0.86

A pulsating auroral X-ray hot spot on Jupiter. Nature (2002) 0.86

Salmonella arizonae bacteremia as the presenting manifestation of human immunodeficiency virus infection following rattlesnake meat ingestion. Rev Infect Dis (1990) 0.86

Early-onset LBSL: how severe does it get? Neuropediatrics (2012) 0.86

Experience with adolescents with phenylketonuria returned to phenylalanine-restricted diets. J Am Diet Assoc (1986) 0.86

Rapid isolation of neuroblastoma plasma membranes on Percoll gradients. Characterization and lipid composition. Biochim Biophys Acta (1985) 0.85

Uptake of radiolabeled galactosyl-(alpha1 goes to 4)-galactosyl-(beta1 goes to 4)-glucosylceramide by human serum lipoproteins in vitro. Biochim Biophys Acta (1976) 0.85

The efficacy of dietary therapy for phenylketonuria. Can Med Assoc J (1971) 0.85

An auroral flare at Jupiter. Nature (2001) 0.85

Savant characteristics in a child with developmental delay and deletion in the short arm of chromosome 20. Dev Med Child Neurol (1995) 0.85

Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria. Arch Dis Child (1998) 0.85

Maternal phenylketonuria collaborative study, obstetric aspects and outcome: the first 6 years. Am J Obstet Gynecol (1992) 0.85

Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders. Mol Genet Metab (2012) 0.84